New-Onset Diabetes and Glucose Regulation Are Significant Determinants of Left Ventricular Hypertrophy in Renal Transplant Recipients

Table 3

HbA1c, PWv, and LVMI values of patients according to NODAT treatment modalities.

	Patients without NODAT ()	Diet and life-style changes ()	Oral antidiabetics ()	Insulin ()	value
HbA1c (%)	5.27 ± 1.131	7.52 ± 0.77	7.20 ± 0.14	8.03 ± 1.46	0.273
PWv (m/s)	6.68 ± 2.16	9.25 ± 1.54	8.58 ± 0.78	9.19 ± 1.54	0.557
LVMI (g/m^2)	125.9 ± 45.05^*	143.80 ± 31.84	170.54 ± 18.46	158.11 ± 66.41^*	0.05^*

 ^* value for LVMI between patients without NODAT and patients with NODAT under insulin therapy.